WASHINGTON, D.C. — U.S. Senator Bob Casey (D-PA) released a statement applauding the White House for steps to address the Nation’s infant formula shortage. Senator Casey has been advocating for families and consumers since Abbott Nutrition announced its recall.
“These are desperate times for families across the country who cannot find and afford formula for their children. I applaud the Biden Administration for taking steps… to begin to address this shortage, but we still need answers from both Abbott and the FDA on what they knew and when. I’m going to keep pushing for answers so no family ever has to go through the fear and frustration parents are feeling now.”
February 24, 2022: Senator Casey, Chair of the Subcommittee on Children and Families on the Senate Health, Education, Labor, and Pensions (HELP) Committee joined Senator Patty Murray (D-WA), Chair of the Senate HELP Committee, to send a letter to Abbott requesting documents and more detail on the recall.
March 22, 2022: Senators Casey and Murray responded to the troubling Form 483s from three FDA inspections conducted at Abbott Nutrition’s facility.
April 8, 2022: Senator Casey and Senator Sherrod Brown (D-OH) sent a letter to FDA Commissioner Califf pressing for answers on their actions and plans to investigate the Abbott reports.
April 29, 2022: Senator Casey raised alarms on the whistleblower report from Abbott.